(Q34669225)

3 August 2017

1 reference

title

Review article: medical treatment of active Crohn's disease (English)

1 reference

3 August 2017

0 references

Scribano ML

1

1 reference

3 August 2017

Prantera C

series ordinal

2

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

Alimentary Pharmacology & Therapeutics

3 August 2017

published in

1 reference

3 August 2017

volume

16 Suppl 4

1 reference

3 August 2017

page(s)

35-39

1 reference

A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study Group.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.16.X

Metronidazole in Crohn's disease. A double blind cross-over clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.16.X

Antibiotic therapy for treatment in relapse of intestinal Crohn's disease. A prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.16.X

Double blind, placebo controlled trial of metronidazole in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.16.X

Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.16.X

Oral budesonide is as effective as oral prednisolone in active Crohn's disease. The Global Budesonide Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.16.X

A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.16.X

Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.16.X

Low-Dose Cyclosporine for the Treatment of Crohn's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.16.X

Methotrexate for the Treatment of Crohn's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.16.X

10.1046/J.1365-2036.16.S4.16.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference